| Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma M Fujisawa, M Sakata-Yanagimoto, S Nishizawa, D Komori, P Gershon, ... Leukemia 32 (3), 694-702, 2018 | 121 | 2018 |
| Dasatinib is an effective treatment for angioimmunoblastic T-cell lymphoma TB Nguyen, M Sakata-Yanagimoto, M Fujisawa, ST Nuhat, H Miyoshi, ... Cancer research 80 (9), 1875-1884, 2020 | 51 | 2020 |
| Droplet digital polymerase chain reaction assay and peptide nucleic acid‐locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T … S Tanzima Nuhat, M Sakata‐Yanagimoto, D Komori, K Hattori, Y Suehara, ... Cancer science 109 (5), 1682-1689, 2018 | 20 | 2018 |
| Recurrent VAV1 Abnormalities in Angioimmunoblastic T Cell Lymphoma D Komori, M Sakata-Yanagimoto, ST Nuhat, K Fukumoto, M Fujisawa, ... Blood 128 (22), 4104, 2016 | 1 | 2016 |
| ACTIVATION OF RHOA-VAV1 SIGNALING AXIS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA M Fujisawa, M Sakata-Yanagimoto, S Nishizawa, D Komori, P Gershon, ... HAEMATOLOGICA 102, 94-94, 2017 | | 2017 |
